WHO urges countries to invest more in research to prevent TB transmission

New Delhi: On the eve of the World TB Day, the World Health Organisation on Friday urged the countries to harness the power of technology for early diagnosis of tuberculosis while stressing on more investment into research to prevent its transmission.

WHO regional director for South-east Asia, Dr Poonam Khetrapal Singh, also asked the countries to ensure all persons that have had contact with a TB patient are traced and also screened for the disease.

“Similarly, greater attention should be given to managing latent TB lest it become active, especially for persons living with HIV. Investing in research aimed at developing tools to prevent TB transmission (and that can be applied to large populations) should likewise be prioritized,” Singh said.

She termed the recent region-wide progress as both significant and highly encouraging, and lauded the member countries for increasing their domestic funding for TB programmes with two of them have done so by more than 100 per cent.

“All member countries have accelerated active case-finding. Patient-centered policies have been developed and implemented, including direct cash transfers and nutritional support for persons suffering TB and plans have been developed to engage civil society organizations,” she said.

Maintaining the Region’s leadership, drive and momentum ahead of September’s High-Level Meeting on TB, which will occur alongside the UN General Assembly, is of vital importance, she said while seeking commitment from all levels of society, starting from the highest offices of government to community health workers and volunteers.

  • Related Posts

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    New Delhi: Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry. “Had…

    Senores Pharma to Buy Two Teva ANDAs

    Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India